AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
229.25
-1.05 (-0.46%)
Oct 14, 2025, 1:33 PM EDT - Market open
AbbVie Stock Forecast
Stock Price Forecast
The 21 analysts that cover AbbVie stock have a consensus rating of "Buy" and an average price target of $230, which forecasts a 0.33% increase in the stock price over the next year. The lowest target is $190 and the highest is $284.
Price Target: $230 (+0.33%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 5 | 6 | 5 |
| Buy | 11 | 11 | 11 | 12 | 12 | 12 |
| Hold | 5 | 5 | 5 | 5 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 23 | 22 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $231 → $284 | Buy | Maintains | $231 → $284 | +23.88% | Oct 10, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $220 → $251 | Hold | Maintains | $220 → $251 | +9.49% | Oct 3, 2025 |
| HSBC | HSBC | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 1, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $207 → $222 | Buy | Maintains | $207 → $222 | -3.16% | Sep 22, 2025 |
| Berenberg | Berenberg | Hold → Strong Buy Upgrades $170 → $270 | Hold → Strong Buy | Upgrades | $170 → $270 | +17.78% | Sep 17, 2025 |
Financial Forecast
Revenue This Year
61.88B
from 56.33B
Increased by 9.85%
Revenue Next Year
67.44B
from 61.88B
Increased by 8.98%
EPS This Year
12.26
from 2.39
Increased by 413.18%
EPS Next Year
14.55
from 12.26
Increased by 18.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 64.5B | 72.2B | |||
| Avg | 61.9B | 67.4B | |||
| Low | 59.0B | 61.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.4% | 16.7% | |||
| Avg | 9.8% | 9.0% | |||
| Low | 4.8% | -0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.94 | 16.35 | |||
| Avg | 12.26 | 14.55 | |||
| Low | 11.59 | 12.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 441.3% | 33.3% | |||
| Avg | 413.2% | 18.6% | |||
| Low | 385.1% | 5.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.